These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25016768)
1. [Specificity of attention and cognitive inhibition processes in relapsing -remitting multiple sclerosis patients with consideration of their mood level]. Tyburski E; Potemkowski A; Cheć M; Sołtys A; Mak M; Samochowiec A Psychiatr Pol; 2014; 48(2):307-18. PubMed ID: 25016768 [TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324 [TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis. Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310 [TBL] [Abstract][Full Text] [Related]
4. Indices of cognitive dysfunction in relapsing-remitting multiple sclerosis: intra-individual variability, processing speed, and attention network efficiency. Wojtowicz M; Omisade A; Fisk JD J Int Neuropsychol Soc; 2013 May; 19(5):551-8. PubMed ID: 23425598 [TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G; Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262 [TBL] [Abstract][Full Text] [Related]
6. Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis. Cogo MG; Rota S; Fusco ML; Mapelli C; Ferri F; Appollonio IM; Isella V J Clin Exp Neuropsychol; 2014; 36(10):1066-75. PubMed ID: 25486588 [TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment in patients with relapsing-remitting multiple sclerosis. The correlation with MRI lesion volume. Karlińska I; Siger M; Lewańska M; Selmaj K Neurol Neurochir Pol; 2008; 42(5):416-23. PubMed ID: 19105110 [TBL] [Abstract][Full Text] [Related]
8. Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis. Kraemer M; Herold M; Uekermann J; Kis B; Daum I; Wiltfang J; Berlit P; Diehl RR; Abdel-Hamid M J Neuropsychol; 2013 Mar; 7(1):91-106. PubMed ID: 23126275 [TBL] [Abstract][Full Text] [Related]
9. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518 [TBL] [Abstract][Full Text] [Related]
10. Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients. Tsivgoulis G; Triantafyllou N; Papageorgiou C; Evangelopoulos ME; Kararizou E; Sfagos C; Vassilopoulos D Acta Neurol Scand; 2007 Jan; 115(1):67-72. PubMed ID: 17156268 [TBL] [Abstract][Full Text] [Related]
11. Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis. Kraemer M; Herold M; Uekermann J; Kis B; Wiltfang J; Daum I; Dziobek I; Berlit P; Diehl RR; Abdel-Hamid M Clin Neurol Neurosurg; 2013 Jul; 115(7):1016-22. PubMed ID: 23199520 [TBL] [Abstract][Full Text] [Related]
12. Impulsivity and attention deficit-hyperactivity symptoms among patients with relapsing-remitting multiple sclerosis: a case-control study. Ceyhun HA; Bilge N; Değirmencioğlu Gök D Neurol Res; 2024 Mar; 46(3):243-252. PubMed ID: 38088158 [TBL] [Abstract][Full Text] [Related]
14. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms. Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264 [TBL] [Abstract][Full Text] [Related]
15. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life. Hayter AL; Salkovskis PM; Silber E; Morris RG Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805 [TBL] [Abstract][Full Text] [Related]
16. [Clinical features of 314 patients with relapsing-remitting multiple sclerosis]. Nogales-Gaete J; Aracena R; Cepeda-Zumaeta S; Eloiza C; Agurto P; Díaz V; Labbé S; Martínez S; Flores J; Araya C Rev Med Chil; 2014 May; 142(5):559-66. PubMed ID: 25427011 [TBL] [Abstract][Full Text] [Related]
17. PASAT in detecting cognitive impairment in relapsing-remitting MS. Rosti E; Hämäläinen P; Koivisto K; Hokkanen L Appl Neuropsychol; 2007; 14(2):101-12. PubMed ID: 17523884 [TBL] [Abstract][Full Text] [Related]
18. [Personality features in multiple sclerosis patients with a relapsing-remitting course of the disease]. Papuć E; Pawłowska B Psychiatr Pol; 2005; 39(4):669-78. PubMed ID: 16237972 [TBL] [Abstract][Full Text] [Related]
19. Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial. Schwid SR; Goodman AD; Weinstein A; McDermott MP; Johnson KP; J Neurol Sci; 2007 Apr; 255(1-2):57-63. PubMed ID: 17331542 [TBL] [Abstract][Full Text] [Related]